A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.

Clinical trial NCT06015048 · RECRUITING

Trial details

NCT number: NCT06015048
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HER2-expressing Advanced Solid Tumors

Start date: 2023-08-11
Primary completion: 2026-11-01
Enrollment: 364

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.